Silacyclic derivatives of heteroaromatic sulfides as selective cholesterol level lowering and vasodilating agents

Metal-Based Drugs

Volumn 8, Issue 6, 2001, Pages 307-313

  Abele, Edgars ^a   Rubina, Kira ^a   Abele, Ramona ^a   Dzenitis, Olges ^a   Arsenyan, Pavel ^a   Popelis, Juris ^a   Veveris, Maris ^a   Meirena, Dainuvite ^a   Lukevics, Edmunds ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 2 [[3 (1 METHYL 1 SILACYCLOPENTYL)PROPYL]THIO]IMIDAZOLE; 1,3,4 TRIAZOLYL THIOL DERIVATIVE; 18 CROWN 6; 2 [[3 (1 METHYL 1 SILACYCLOPENTYL)PROPYL]THIO]BENZOTHIAZOLE; 2 [[3 (1 METHYL 1 SILACYCLOPENTYL)PROPYL]THIO]BENZOXAZOLE; 3 [[3 (1 METHYL 1 SILACYCLOPENTYL)PROPYL]THIO] 4 [3 (1 METHYL 1 SILACYCLOPENTYL)PROPYL] 1,2,4 TRIAZOLE; BENZOXAZOLE DERIVATIVE; BENZOXAZOLYL THIOL DERIVATIVE; CHOLESTEROL; CROWN ETHER DERIVATIVE; DIMETHYL(BETA TRIETHYLGERMYLETHYL)SILYMETHYL IMIDAZOLE; HETEROAROMATIC SULFIDE; HIGH DENSITY LIPOPROTEIN; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN; N METHYLIMIDAZOLYL THIOL DERIVATIVE; SILACYCLIC DERIVATIVE; SILACYCLOPROPYL IODIDE; SULFIDE; THIOL; TOLUENE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ARTICLE; CATALYSIS; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; LIPOPHILICITY; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; NUTRITION;

EID: 0035555274     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.2002.307     Document Type: Article

References (50)